Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Margit Rosner

Showing results (1-10 of 79) with videos related to

Pageof 8
Sort By:
Stem Cells Translational Medicine|May 31, 2022
Stem Cell-Induced Cell Motility: A Removable Obstacle on the Way to Safe Therapies?Margit Rosner, Markus Hengstschläger
Current Stem Cell Research & Therapy|December 13, 2021
Amniotic Fluid Stem Cells: What They Are and What They Can BecomeMargit Rosner, Markus Hengstschläger
Trends in Molecular Medicine|January 23, 2013
Amniotic fluid stem cells and fetal cell microchimerismMargit Rosner, Markus Hengstschläger
Stem Cells (Dayton, Ohio)|July 12, 2016
Letter to the Editor: Human Pluripotent Stem Cells Release Oncogenic Soluble E-CadherinMargit Rosner, Markus Hengstschläger
Stem Cells (Dayton, Ohio)|July 31, 2021
Three-dimensional migration of human amniotic fluid stem cells involves mesenchymal and amoeboid modes and is regulated by mTORC1Margit Rosner, Markus Hengstschläger
Human Molecular Genetics|July 11, 2008
Cytoplasmic and nuclear distribution of the protein complexes mTORC1 and mTORC2: rapamycin triggers dephosphorylation and delocalization of the mTORC2 components rictor and sin1Margit Rosner, Markus Hengstschläger
Cell Cycle (Georgetown, Tex.)|October 26, 2011
mTOR protein localization is cell cycle-regulatedMargit Rosner, Markus Hengstschläger
Clinical Chemistry|May 19, 2022
Fetomaternal Microchimerism and Amniotic Fluid Stem Cells: The Current State of KnowledgeMargit Rosner, Markus Hengstschläger
The Journal of Biological Chemistry|September 10, 2004
Tuberin binds p27 and negatively regulates its interaction with the SCF component Skp2Margit Rosner, Markus Hengstschläger
Progress in Cell Cycle Research|November 5, 2003
The cell cycle and tuberous sclerosisMarkus Hengstschläger, Margit Rosner
Pageof 8

Showing results (1-10 of 79) with videos related to

Sort By:
Pageof 8
Stem Cells Translational Medicine|May 31, 2022
Stem Cell-Induced Cell Motility: A Removable Obstacle on the Way to Safe Therapies?Margit Rosner, Markus Hengstschläger
Current Stem Cell Research & Therapy|December 13, 2021
Amniotic Fluid Stem Cells: What They Are and What They Can BecomeMargit Rosner, Markus Hengstschläger
Trends in Molecular Medicine|January 23, 2013
Amniotic fluid stem cells and fetal cell microchimerismMargit Rosner, Markus Hengstschläger
Stem Cells (Dayton, Ohio)|July 12, 2016
Letter to the Editor: Human Pluripotent Stem Cells Release Oncogenic Soluble E-CadherinMargit Rosner, Markus Hengstschläger
Stem Cells (Dayton, Ohio)|July 31, 2021
Three-dimensional migration of human amniotic fluid stem cells involves mesenchymal and amoeboid modes and is regulated by mTORC1Margit Rosner, Markus Hengstschläger
Human Molecular Genetics|July 11, 2008
Cytoplasmic and nuclear distribution of the protein complexes mTORC1 and mTORC2: rapamycin triggers dephosphorylation and delocalization of the mTORC2 components rictor and sin1Margit Rosner, Markus Hengstschläger
Cell Cycle (Georgetown, Tex.)|October 26, 2011
mTOR protein localization is cell cycle-regulatedMargit Rosner, Markus Hengstschläger
Clinical Chemistry|May 19, 2022
Fetomaternal Microchimerism and Amniotic Fluid Stem Cells: The Current State of KnowledgeMargit Rosner, Markus Hengstschläger
The Journal of Biological Chemistry|September 10, 2004
Tuberin binds p27 and negatively regulates its interaction with the SCF component Skp2Margit Rosner, Markus Hengstschläger
Progress in Cell Cycle Research|November 5, 2003
The cell cycle and tuberous sclerosisMarkus Hengstschläger, Margit Rosner
Pageof 8